Patent · US Active

Treatment of intrahepatic cholestatic diseases

US10478411B2 · kind B2 · utility

1Cited by
20References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 28, 2019
Grant dateNov 19, 2019
Priority date—
Expiry dateMar 28, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/16
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Treatment of intrahepatic cholestatic diseases by therapy with seladelpar or a salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.